Announcement
The remarkable gift will support the LABS (Lustgarten Advancing Breakthrough Science) Program. WOODBURY, N.Y., May 1, 2024 — The Lustgarten Foundation today announced a remarkable $500,000 donation from The Warren […]
Over 300 pancreatic cancer supporters united at Hudson River Park’s Pier 84 in New York City New York, N.Y., Apr 22, 2024 — Over 300 pancreatic cancer supporters united at […]
WOODBURY, NY, April 11, 2024 – The Lustgarten Foundation, in collaboration with the American Association for Cancer Research (AACR), has announced the 2024 recipients of the Lustgarten-AACR Career Development Awards […]
LUSTGARTEN FUNDED RESEARCH: An adjuvant treatment regimen that included autogene cevumeran, an investigational individualized neoantigen-specific mRNA vaccine, induced durable and functional T-cell responses that were associated with a reduced risk […]
LUSTGARTEN FUNDED RESEARCH: A novel treatment for leukemias and lymphomas that arise from immune system T cells, developed by investigators at the Johns Hopkins Kimmel Cancer Center and its Ludwig […]
LUSTGARTEN FUNDED RESEARCH: Researchers at the University of Toronto’s Donnelly Centre for Cellular and Biomolecular Research have found two enzymes that work against the chemotherapy drug gemcitabine, preventing it from effectively treating […]
Join us for an evening of stunning skyline vistas, unparalleled ambiance, exquisite cocktails and culinary delights – all while supporting groundbreaking pancreatic cancer research.
Dr. Elizabeth Legatt In 2019, retired obstetrician/gynecologist and thyroid cancer survivor Dr. Elizabeth Legatt, then 68, suddenly became prediabetic, and she didn’t know why. There had been no change in […]